Skip to content

Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors

Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01922323
Enrollment
20
Registered
2013-08-14
Start date
2013-08-31
Completion date
2016-09-26
Last updated
2017-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Insufficiency

Keywords

Living liver donor

Brief summary

The PI will study metabolism during liver regeneration in living liver donors

Detailed description

Samples of blood and urine will be collected from study participants at defined timepoints. The samples will be evaluated to study the metabolism of the regenerating liver after a portion of the liver has been donated from a living donor.

Interventions

None listed

Sponsors

Baylor Research Institute
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

1. Potential donor must be in excellent medical and psychological health. 2. Potential donor must be between the ages of 18 and 60. 3. Must have a compatible blood type to the recipient. 4. Must have health care coverage for non-donor related health issues that arise post donation 5. Recipient and donor must have compatible body size. 6. Donors Body Mass Index (BMI) must be less than 30. 7. All previous donor abdominal surgeries will be reviewed on a case by case basis by the surgeon.

Exclusion criteria

1. Positive blood test for Human Immunodeficiency Virus, Hepatitis C virus, Hepatitis B virus 2. The size of the donor liver is not large enough to safely resection and still retain enough volume to function normally after the surgery. 3. Liver biopsy show liver cirrhosis or early stages of HCC. \- \-

Design outcomes

Primary

MeasureTime frame
Characterized Metabolic Changes during liver regenerationone year after donation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026